Retatrutide: Clinical Trials & Research
33 registered clinical trials and 78 peer-reviewed publications indexed for Retatrutide, sourced from ClinicalTrials.gov and PubMed.
Clinical trials
- Effect of LY3437943 Versus Placebo in Participants Who Have Obesity or Are Overweight
- A Study of Retatrutide (LY3437943) in Participants Without Type 2 Diabetes Who Have Obesity or Overweight
- A Study of Retatrutide (LY3437943) in Participants With Obesity or Overweight
- A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease…
- A Study to Investigate the Response of Participants With Type 2 Diabetes Mellitus on Once-Weekly Retatrutide to…
Research papers
- Retatrutide-Associated Improvements in Cardiovascular Risk Biomarkers in Adults With Obesity With or Without Type 2…
- Comparative effects of semaglutide tirzepatide and retatrutide on renal fibrosis in UUO and aged mice
- Composition and Labelling Accuracy of Products Sold as Retatrutide in Australia
- Retatrutide: Obesity drug opens to "compassionate use" in US after speculation Trump took it
- Retatrutide effects on diabetic rats' cognition
See also: Retatrutide full profile.
Study summaries on this site: Effect of Retatrutide, a Novel Triple Receptor Agonist, on Blood Pressure and Lipid…, Effects of retatrutide on learning and memory in streptozotocin-induced male diabetic rats, Efficacy and safety of retatrutide, a GIP, GLP-1, and glucagon receptor agonist, in…, Retatrutide-Associated Improvements in Cardiovascular Risk Biomarkers in Adults With….